Veröffentlichungen

Artikel

Sollte einer der verlinkten Artikel nicht im Volltext für Sie erreichbar sein (bspw. weil dieser nur mit einem Abonement verfügbar ist) sprechen Sie uns gerne an.

Bitte beachten Sie auch die weiteren Arten von Veröffentlichungen (Poster / Vorträge / Broschüren / Grafiken des Quartals)

Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry

Blaschke SJ, Ellenberger D, Flachenecker P, Hellwig K, Paul F, Pöhlau D, Kleinschnitz C, Rommer PS, Rueger MA, Zettl UK, Stahmann A, Warnke C, 2021: MSJ Article first published online: August 27, 2021, doi:10.1177/13524585211039753

Prevalence of pediatric multiple sclerosis in Germany - a nationwide population-based analysis

Frahm N*, Peters M*, Bätzing J, Ellenberger D, Akmatov MK, Haas J, Rommer PS, Stahmann A, Zettl UK, Holstiege J, 2021: European Journal of Neurology Vol 28, Issue 9, p3173-3176, first published online: July 9, 2021 doi:10.1111/ene.15015

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry

Ohle LM, Ellenberger D, Flachenecker P, Friede T, Haas J, Hellwig K, Parciak T, Paul F, Warnke C, Stahmann A, 2021: Scientific Reports, Vol. 11, Article number: 13340 (2021); published online: June 25, 2021 doi:10.1038/s41598-021-92722-x

Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care

Jalusic K, Stahmann A, et. al, 2021: MSJ Article first published online: January 20, 2021; doi:10.1177/1352458520985118

Multiple Sclerosis Data Alliance – A global multi-stakeholder collaboration to scale-up real world data research

Peeters, L et al.; 2021: Multiple Sclerosis and Related Disorders, Vol. 47 : Januar 2021; doi:10.1016/j.msard.2020.102634

Aggressive multiple sclerosis – a matter of measurement and timing

Ellenberger D, Flachenecker P, Fneish F, Frahm N,Hellwig K, Paul F, Stahmann A, Warnke C, Rommer PS, Zettl UK; 2020: BRAIN published online: September 2020; doi:10.1093/brain/awaa306
 

Relapsing and progressive MS: the sex-specific perspective

Rommer PS, Ellenberger D, Hellwig K, Haas J, Pöhlau D, Stahmann A, Zettl UK, on behalf of the Scientific Advisory Group of the German MS-Register by the German MS Society, 2020: Therapeutic Advances in Neurological Disorders published online: September 2020; doi:10.1177/1756286420956495

Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration

Ellenberger D, Flachenecker P, Haas J, Hellwig K, Paul F, Stahmann A, Warnke C, Zettl UK, Rommer PS, 2020: Multiple Sclerosis and Related Disorders published online: September 2020; doi:10.1016/j.msard.2020.102485

Management of MS patients treated with daclizumab - a case series of 267 patients

Rommer PS, Berger K, Ellenberger D, Fneish F, Simbrich A, Stahmann A, Zettl K, 2020: Frontiers in Neurology published online: July 29, 2020; doi:10.3389/fneur.2020.00996

COVID-19 in people with multiple sclerosis: A global data sharing initiative

Peeters L, Stahmann A, et. al, 2020: MSJ Article first published online: July 14, 2020; doi:10.1177/1352458520941485

Explorative Study of Emerging Blood Biomarkers in Progressive Multiple Sclerosis (EmBioProMS): Design of a Prospective Observational Multicentre Pilot Study

A Abdelhak, A Huss, A Stahmann, M Senel, M Krumbholz, M C Kowarik, J Havla, et al, 2020: Contemporary Clinical Trials Communications, May 19, 2020, doi: 10.1016/j.conctc.2020.100574 

Data harmonization for collaborative research among MS registries: A case study in employment

Salter, A, Stahmann, A, Ellenberger, D et. al, 2020: MSJ Article first published online: March 12, 2020; doi:10.1177/1352458520910499

 

Multiple sclerosis registries in Europe – an updated mapping survey

Glaser et. al, 2018: Multiple Sclerosis and Related Disorders, doi:10.1016/j.msard.2018.09.032 , Volume  27 (2019), S. 171–178 published online ahead of print
 

Symptomatology Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry

Rommer et. al, 2018 (published online ahead of print): Multiple Sclerosis Journal, Volume 25, Issue 12, 1641-1652, doi: 10.1177/1352458518799580,

Decreasing longitudinal use of glucocorticosteroids in multiple sclerosis

Ellenberger et al, 2018: Multiple Sclerosis and Related Disorders, doi: 10.1016/j.msard.2018.07.040, Volume 25, 173-174
 

MS in Deutschland: Symptome und Behandlungsdefizite

Zettl et al, 2018: Neurotransmitter, doi:10.1007/s15016-018-6423-8, Volume 29 [Issue 6] S. 42-44
 

Neuroimmunologische Register in Deutschland

Thiel et. al, 2018: Akt Neurol 2018; 45(01): 7-23 doi:10.1055/s-0043-108909, Type: http/URL
 

„Symptomatic treatment in multiple sclerosis—interim analysis of a nationwide registry“

Veröffentlicht: 9. Juni 2016 (online), in Acta Neurologica Scandinavica, doi:10.1111/ane.12612, Volume 135 [Issue 4] S.394-399 (April 2017), Type: http/URL
 

„Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis – an observational study“

Veröffentlicht: 9. Mai 2015 (online), in European Journal of Clinical Investigation, doi:10.1111/eci.12450, Volume 45 [Issue 6] S.587-593 (Juni 2015), Type: http/URL
 

Entwicklung einer App für die Integration von PRO-Daten in das nationale MS-Register – Zwischenergebnisse einer Machbarkeitsstudie

Veröffentlicht: September 2014, GMDS 2014: 59. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS), Göttingen, doi: 10.3205/14gmds234 Type: http/URL
 

„Multiple Sclerosis Registries in Europe – Results of a Systematic Survey“.

Veröffentlicht: 28. April 2014 (online), in Multiple Sclerosis Journal, doi:10.1177/1352458514528760, Volume 20 [Issue 11] S.1523-1532 (Oktober 2014), Type: http/URL
 

Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe

Veröffentlicht: Dezember 2012 in Acta Neurologica Scandinavica, Volume 126 [Issue s195] S.24–30, doi:10.1111/ane.12024, Type: http/URL
 

Making EUReMS count for people with multiple sclerosis

Veröffentlicht: Oktober 2011 in The Lancet Neurology - Editorial, doi:10.1016/S1474-4422(11)70215-0, Volume 10 [Issue 10], page 865, Type: http/URL
 

Development and pilot phase of a European MS register

Veröffentlicht: 2010 in Journal of Neurology; Volume 257 [Issue 10] S.1620-1627, doi:10.1007/s00415-010-5578-4, Type: http/URL
 

Symptomatology of MS: results from the German MS Registry

Veröffentlicht: 2009 in Journal of Neurology; Volume 256 [Issue 11] S.1932-1935, doi:10.1007/s00415-009-5257-5, Type: http/URL
 

National MS registries

Veröffentlicht: 2008 in Journal of Neurology, doi:10.1007/s00415-008-6019-5; Volume 255 [Suppl 6] S.102–108, Type: http/URL
 

Multiple-Sklerose-Register in Deutschland

Veröffentlicht: 15. Februar 2008 in Deutsches Ärzteblatt; Volume 105 [Issue 7] S.113-119, Type: http/URL
 

MS-Register in Deutschland: Abschließende Ergebnisse der Pilotphase

Veröffentlicht: 2007 in Neurol Rehabil; Volume 13 [Issue 4] S.193 – 200, Type: http/URL